Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

EGX:AXPH Income Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	2,751	1,768	1,484	1,100	1,104
Other Revenue	-	-	-	0	-
Revenue	2,751	1,768	1,484	1,100	1,104
Revenue Growth (YoY)	55.56%	19.12%	34.94%	-0.38%	7.75%
Cost of Revenue	2,092	1,373	1,223	876.78	841.45
Gross Profit	658.95	395.18	260.89	223.24	262.8
Selling, General & Admin	102.21	89.77	83.52	75.65	93.71
Other Operating Expenses	52.04	37.92	22.44	13.05	14.98
Operating Expenses	154.25	127.69	105.96	88.7	108.69
Operating Income	504.7	267.49	154.92	134.54	154.11
Interest & Investment Income	19.56	13.52	5.52	5.55	2.82
Currency Exchange Gain (Loss)	-3.01	8.03	11.57	4.4	-0.24
Other Non Operating Income (Expenses)	-	0	0	-	0
EBT Excluding Unusual Items	521.25	289.04	172.02	144.49	156.69
Gain (Loss) on Sale of Assets	-	0.56	1.03	-	0.4
Other Unusual Items	-12.34	-7.57	-8.1	-0.99	-5.5
Pretax Income	508.9	282.03	164.95	143.5	151.59
Income Tax Expense	117.74	65.35	38.52	26.08	34.59
Net Income	391.17	216.68	126.43	117.42	117
Net Income to Common	391.17	216.68	126.43	117.42	117
Net Income Growth	80.53%	71.39%	7.67%	0.36%	-31.20%
Shares Outstanding (Basic)	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5
Shares Change (YoY)	-	-	-	-	-15.35%
EPS (Basic)	78.23	43.34	25.29	23.48	23.40
EPS (Diluted)	78.23	43.34	25.29	23.48	23.40
EPS Growth	80.53%	71.39%	7.67%	0.36%	-18.73%
Free Cash Flow	306.27	127.41	7.09	160.9	-20.57
Free Cash Flow Per Share	61.25	25.48	1.42	32.18	-4.11
Dividend Per Share	62.950	30.000	13.000	-	10.000
Dividend Growth	109.83%	130.77%	-	-	-35.48%
Gross Margin	23.96%	22.35%	17.58%	20.29%	23.80%
Operating Margin	18.35%	15.13%	10.44%	12.23%	13.96%
Profit Margin	14.22%	12.26%	8.52%	10.67%	10.60%
Free Cash Flow Margin	11.13%	7.21%	0.48%	14.63%	-1.86%
EBITDA	547.92	305.05	182.92	157.73	177.74
EBITDA Margin	19.92%	17.25%	12.32%	14.34%	16.10%
D&A For EBITDA	43.22	37.56	28	23.18	23.63
EBIT	504.7	267.49	154.92	134.54	154.11
EBIT Margin	18.35%	15.13%	10.44%	12.23%	13.96%
Effective Tax Rate	23.14%	23.17%	23.35%	18.17%	22.82%
Revenue as Reported	2,762	1,777	1,486	1,101	1,111

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.